Safety and Effectiveness of D-Cycloserine in Children With Autism
A Randomized Controlled Trial of D-Cycloserine in Autism
Sponsor: Indiana University
This PHASE3 trial investigates Autistic Disorder and is currently completed. Indiana University leads this study, which shows 5 recorded versions since 2004 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE3
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE3
First recorded
Feb 2004
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Indiana University
- Indiana University School of Medicine
- National Alliance for Research on Schizophrenia and Depression
- National Institute of Mental Health (NIMH)
For direct contact, visit the study record on ClinicalTrials.gov .